CClinicalTrials.gg
CompletedNCT06555302Updated Jun 3, 2026Results posted

Cognitive Priming for Stroke Tele-rehabilitation

An interventional study of Cognitive Rehabilitation and Occupational Therapy in Stroke, sponsored by Medical University of South Carolina. Completed at 1 site in United States. Open to participants aged 21 Years and older. Per ClinicalTrials.gov, last updated 2026-06-03.

Sponsored by Medical University of South Carolina · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
20
Allocation
Not applicable
Ages
21 Years and older
Sex
All
01

Study summary

The goal of this pilot study is to investigate whether adding cognitive rehabilitation to an existing occupational therapy (OT) stroke telerehabilitation program will improve stroke survivors' functioning. The main question it aims to answer is whether this intervention improves cognition, participation, upper extremity use in real-world activities, and mood/quality of life. Participants will be asked to engage in an 8-week stroke tele-rehabilitation program (13 sessions), which includes both cognitive rehabilitation and OT for arm/hand function, and complete assessments before and after the intervention.

02

Conditions studied

  • Stroke

Browse trials for

03

In context

Stroke

7,286 studies on the registry are indexed under Stroke; 2,007 are open to participants now.

This study's enrollment of 20 is below the median of 50 across 5,369 interventional studies indexed under Stroke.

Browse Stroke studies →

Lead sponsor

Medical University of South Carolina is the lead sponsor of 852 studies on the registry; 165 are open to participants now.

Of its 128 completed or terminated interventional studies of FDA-regulated products, 101 (79%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
21 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Have experienced ischemic or hemorrhagic stroke with resultant paresis of one arm/hand at least 30 days prior
  • Adults ages 21 years or older
  • Are able to speak and read English
  • Have corrected vision to be able to read text on a screen
  • Have a device on which a telerehabilitation visit can be conducted (i.e., phone, tablet, or laptop) and a Wi-Fi connection or cellular service
  • Able to participate in the study's assessment sessions as per the judgment of the licensed, experienced stroke telerehabilitation occupational therapist.

Exclusion criteria

Exclusion Criteria:

  • Have moderate-severe or severe aphasia.
  • Have impaired decision making capacity as determined by a standard protocol for assessing capacity to provide informed consent.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
20 participants (actual)

Study arms

  • Experimental
    Cognitive Rehabilitation + Occupational Therapy (Telerehabilitation)

    A trained OT will deliver the 8-week stroke telerehabilitation program. There will be 13 total sessions with 2 sessions/week for the first 5 weeks and 1 session/week for the last 3 weeks. The cognitive rehabilitation and OT components will be titrated as follows: * Sessions 1-4 will focus on cognitive rehab. * Sessions 5-10 will review/provide additional cognitive rehab and deliver OT. * Sessions 11-13 may briefly review cognitive rehab but focus primarily on OT.

    Behavioral: Cognitive Rehabilitation · Behavioral: Occupational Therapy

Interventions

  • BehavioralCognitive Rehabilitation

    Cognitive rehabilitation will be OT-led, one-on-one sessions focused on teaching cognitive strategies and their application to a broad set of activities/settings. The goal is to facilitate cognitive skill learning and generalization, by applying the new cognitive strategies to the participant's performance of home-based and community-based activities (taught through the subsequent OT portion of the intervention).

  • BehavioralOccupational Therapy

    OT upper extremity rehabilitation will have 2 components: task-practice and metacognitive strategy training. The task-practice involves a patient repetitively practicing stroke-impaired movement skills within the context of a functional task to promote recovery of the impaired skills. THE task practice sessions will be coached/guided by the therapist through a metacognitive strategy training process which is based on the Cognitive Orientation to Occupational Performance (CO-OP) approach aimed at enhancing self-management during home and community living tasks.

06

What researchers measure

Primary outcomes

  1. Change From Baseline in Global Cognition, as Measured by the Montreal Cognitive Assessment (MoCA)

    Montreal Cognitive Assessment (MoCA) is a 16-item objective cognitive screening measure. Total scores range from 0-30 points, with higher scores indicating better cognition.

    Time frame: From pre-treatment assessment to post-treatment assessment, up to approximately 10 weeks

  2. Change From Baseline Functional Task Performance and Activity Participation, as Measured by the Patient Specific Functional Scale (PSFS)

    The Patient Specific Functional Scale (PSFS) is a patient-reported measure of task-goal identification and difficulty performing the task on a 0-10-point ordinal scale with higher ratings indicating greater satisfaction with task performance.

    Time frame: From pre-treatment assessment to post-treatment assessment, up to approximately 10 weeks

  3. Change From Baseline Psychosocial Function (Depression), as Measured by the Patient Health Questionnaire (PHQ-9)

    The Patient Health Questionnaire (PHQ-9) is a 9-item self-report measure of depression. Items query mood (feeling down, lack of interest), thoughts (guilt, suicidality), and physical symptoms (appetite, sleep, fatigue, concentration, restlessness). Each item is scored on a 4-point scale reflecting how often the symptom has occurred over the last 2 weeks (0=not at all, 3=nearly every day). Scores are summed (out of 27), with higher scores indicating more symptoms of depression.

    Time frame: From pre-treatment assessment to post-treatment assessment, up to approximately 10 weeks

Secondary outcomes

  1. Change From Baseline Subjective Cognition, as Measured by the NeuroQoL-Cognitive Function

    The NeuroQoL-Cognitive Function Short Form v.2.0 is a 29-item subjective measure of cognitive function. This patient-reported outcome assesses perceived abilities in memory, attention, decision making, or in the application of such abilities to everyday tasks (e.g., planning, organizing, calculating, remembering, and learning) on a 5-item rating scale (1=cannot do to 5=no difficulty). The summed raw score is converted into a normed T-score (mean=50, SD=10). Higher T-scores reflect better perceived cognitive function.

    Time frame: From pre-treatment assessment to post-treatment assessment, up to approximately 10 weeks

  2. Change From Baseline Functional Task Performance and Activity Participation, as Measured by the Performance Quality Rating Scale (PQRS)

    The Performance Quality Rating Scale (PQRS) is a therapist-rated measure. The OT observes the participant's performance of a specific task and rates it on a 0-10-point ordinal scale, with higher ratings indicating greater task performance skill.

    Time frame: From intervention session #5 to intervention session #13 (approximately 5 weeks)

  3. Change From Baseline Functional Task Performance and Activity Participation, as Measured by the Stroke Self Efficacy Questionnaire (SSEQ)

    The Stroke Self Efficacy Questionnaire (SSEQ) is a 13-item self-report measure of confidence (0-10-point Likert scale with higher numbers indicating greater confidence) doing at-home tasks such as using both hands to eat food or prepare a meal for oneself. Item scores are summed and total range from 0-130, with higher scores indicating greater self-efficacy.

    Time frame: From pre-treatment assessment to post-treatment assessment, up to approximately 10 weeks

  4. Change From Baseline Psychosocial Function (Global), as Measured by the Inventory of Psychosocial Functioning (IPF)

    The Inventory of Psychosocial Functioning (IPF) is an 80-item self-report measure of impairment in 7 psychosocial domains within the last 30 days: romantic relationships, family, work, friendships and socializing, parenting, education, and self-care. Participants rate the frequency of difficulty on each item on a 7-point scale (0=never, 6=always). Scores are averaged by domain (if ≥80% of items are complete) and multiplied by 100; an overall score (grand mean, range: 0-100) is the average of completed domain scores; higher scores indicate greater impairment in psychosocial function.

    Time frame: From pre-treatment assessment to post-treatment assessment, up to approximately 10 weeks

  5. Change From Baseline Psychosocial Function (Sleep), as Measured by the PROMIS Sleep Disturbance

    PROMIS Sleep Disturbance is an 8-item self-report measure of perceived difficulties falling and/or staying asleep. Items are rated on a 5-point rating scale (1=no problem, 5=very much a problem). The summed raw score is converted into a normed T-score (mean=50, SD=10). Higher T-scores reflect more sleep disturbance.

    Time frame: From pre-treatment assessment to post-treatment assessment, up to approximately 10 weeks

07

Results

Posted May 14, 2026

Participant flow

Participants were recruited from the MUSC Stroke Recovery Research Center's Registry for Stroke Recovery (RESTORE). They were recruited between 8/7/2024 and 2/12/2025. The first participant was enrolled on 8/20/2024 and the last participant was enrolled on 2/12/2025.

Participant flow — Overall Study
MilestoneCognitive Rehabilitation + Occupational Therapy (Telerehabilitation)
Started20
Completed19
Not completed1
Withdrew: Withdrawal by subject1

Outcome measures

PrimaryChange From Baseline in Global Cognition, as Measured by the Montreal Cognitive Assessment (MoCA)

Montreal Cognitive Assessment (MoCA) is a 16-item objective cognitive screening measure. Total scores range from 0-30 points, with higher scores indicating better cognition.

Time frame:
From pre-treatment assessment to post-treatment assessment, up to approximately 10 weeks
Reported as:
Mean · total score
Change From Baseline in Global Cognition, as Measured by the Montreal Cognitive Assessment (MoCA)
total scoreCognitive Rehabilitation + Occupational Therapy (Telerehabilitation)
Change From Baseline in Global Cognition, as Measured by the Montreal Cognitive Assessment (MoCA)1.74 ± 2.73
Statistical analysis
  • Cognitive Rehabilitation + Occupational Therapy (Telerehabilitation) · t-test, 2 sided · p = .012 · Mean difference (final values): 1.73 · 95% CI .42 to 3.05
PrimaryChange From Baseline Functional Task Performance and Activity Participation, as Measured by the Patient Specific Functional Scale (PSFS)

The Patient Specific Functional Scale (PSFS) is a patient-reported measure of task-goal identification and difficulty performing the task on a 0-10-point ordinal scale with higher ratings indicating greater satisfaction with task performance.

Time frame:
From pre-treatment assessment to post-treatment assessment, up to approximately 10 weeks
Reported as:
Mean · score on scale
Change From Baseline Functional Task Performance and Activity Participation, as Measured by the Patient Specific Functional Scale (PSFS)
score on scaleCognitive Rehabilitation + Occupational Therapy (Telerehabilitation)
Change From Baseline Functional Task Performance and Activity Participation, as Measured by the Patient Specific Functional Scale (PSFS)2.84 ± 2.05
Statistical analysis
  • Cognitive Rehabilitation + Occupational Therapy (Telerehabilitation) · t-test, 2 sided · p = .000 · Mean difference (final values): 2.8 · 95% CI 1.9 to 3.8
PrimaryChange From Baseline Psychosocial Function (Depression), as Measured by the Patient Health Questionnaire (PHQ-9)

The Patient Health Questionnaire (PHQ-9) is a 9-item self-report measure of depression. Items query mood (feeling down, lack of interest), thoughts (guilt, suicidality), and physical symptoms (appetite, sleep, fatigue, concentration, restlessness). Each item is scored on a 4-point scale reflecting how often the symptom has occurred over the last 2 weeks (0=not at all, 3=nearly every day). Scores are summed (out of 27), with higher scores indicating more symptoms of depression.

Time frame:
From pre-treatment assessment to post-treatment assessment, up to approximately 10 weeks
Reported as:
Mean · score on scale
Change From Baseline Psychosocial Function (Depression), as Measured by the Patient Health Questionnaire (PHQ-9)
score on scaleCognitive Rehabilitation + Occupational Therapy (Telerehabilitation)
Change From Baseline Psychosocial Function (Depression), as Measured by the Patient Health Questionnaire (PHQ-9)-0.26 ± 5.61
Statistical analysis
  • Cognitive Rehabilitation + Occupational Therapy (Telerehabilitation) · t-test, 2 sided · p = .840 · Mean difference (final values): -.26 · 95% CI -2.9 to 2.4
SecondaryChange From Baseline Subjective Cognition, as Measured by the NeuroQoL-Cognitive Function

The NeuroQoL-Cognitive Function Short Form v.2.0 is a 29-item subjective measure of cognitive function. This patient-reported outcome assesses perceived abilities in memory, attention, decision making, or in the application of such abilities to everyday tasks (e.g., planning, organizing, calculating, remembering, and learning) on a 5-item rating scale (1=cannot do to 5=no difficulty). The summed raw score is converted into a normed T-score (mean=50, SD=10). Higher T-scores reflect better perceived cognitive function.

Time frame:
From pre-treatment assessment to post-treatment assessment, up to approximately 10 weeks
Reported as:
Mean · t-score
Change From Baseline Subjective Cognition, as Measured by the NeuroQoL-Cognitive Function
t-scoreCognitive Rehabilitation + Occupational Therapy (Telerehabilitation)
Change From Baseline Subjective Cognition, as Measured by the NeuroQoL-Cognitive Function0.78 ± 8.59
Statistical analysis
  • Cognitive Rehabilitation + Occupational Therapy (Telerehabilitation) · t-test, 2 sided · p = .697 · Mean difference (final values): .78 · 95% CI -3.4 to 4.9
SecondaryChange From Baseline Functional Task Performance and Activity Participation, as Measured by the Performance Quality Rating Scale (PQRS)

The Performance Quality Rating Scale (PQRS) is a therapist-rated measure. The OT observes the participant's performance of a specific task and rates it on a 0-10-point ordinal scale, with higher ratings indicating greater task performance skill.

Time frame:
From intervention session #5 to intervention session #13 (approximately 5 weeks)
Reported as:
Mean · score on scale
Change From Baseline Functional Task Performance and Activity Participation, as Measured by the Performance Quality Rating Scale (PQRS)
score on scaleCognitive Rehabilitation + Occupational Therapy (Telerehabilitation)
Change From Baseline Functional Task Performance and Activity Participation, as Measured by the Performance Quality Rating Scale (PQRS)0.53 ± 0.70
Statistical analysis
  • Cognitive Rehabilitation + Occupational Therapy (Telerehabilitation) · t-test, 2 sided · p = .004 · Mean difference (final values): .53 · 95% CI .19 to .86
SecondaryChange From Baseline Functional Task Performance and Activity Participation, as Measured by the Stroke Self Efficacy Questionnaire (SSEQ)

The Stroke Self Efficacy Questionnaire (SSEQ) is a 13-item self-report measure of confidence (0-10-point Likert scale with higher numbers indicating greater confidence) doing at-home tasks such as using both hands to eat food or prepare a meal for oneself. Item scores are summed and total range from 0-130, with higher scores indicating greater self-efficacy.

Time frame:
From pre-treatment assessment to post-treatment assessment, up to approximately 10 weeks
Reported as:
Mean · score on scale
Change From Baseline Functional Task Performance and Activity Participation, as Measured by the Stroke Self Efficacy Questionnaire (SSEQ)
score on scaleCognitive Rehabilitation + Occupational Therapy (Telerehabilitation)
Change From Baseline Functional Task Performance and Activity Participation, as Measured by the Stroke Self Efficacy Questionnaire (SSEQ)6.79 ± 18.20
Statistical analysis
  • Cognitive Rehabilitation + Occupational Therapy (Telerehabilitation) · t-test, 2 sided · p = .121 · Mean difference (final values): 6.79 · 95% CI -1.98 to 15.6
SecondaryChange From Baseline Psychosocial Function (Global), as Measured by the Inventory of Psychosocial Functioning (IPF)

The Inventory of Psychosocial Functioning (IPF) is an 80-item self-report measure of impairment in 7 psychosocial domains within the last 30 days: romantic relationships, family, work, friendships and socializing, parenting, education, and self-care. Participants rate the frequency of difficulty on each item on a 7-point scale (0=never, 6=always). Scores are averaged by domain (if ≥80% of items are complete) and multiplied by 100; an overall score (grand mean, range: 0-100) is the average of completed domain scores; higher scores indicate greater impairment in psychosocial function.

Time frame:
From pre-treatment assessment to post-treatment assessment, up to approximately 10 weeks
Reported as:
Mean · score on scale
Change From Baseline Psychosocial Function (Global), as Measured by the Inventory of Psychosocial Functioning (IPF)
score on scaleCognitive Rehabilitation + Occupational Therapy (Telerehabilitation)
Change From Baseline Psychosocial Function (Global), as Measured by the Inventory of Psychosocial Functioning (IPF)-1.32 ± 10.92
Statistical analysis
  • Cognitive Rehabilitation + Occupational Therapy (Telerehabilitation) · t-test, 2 sided · p = .604 · Mean difference (final values): -1.32 · 95% CI -6.6 to 3.9
SecondaryChange From Baseline Psychosocial Function (Sleep), as Measured by the PROMIS Sleep Disturbance

PROMIS Sleep Disturbance is an 8-item self-report measure of perceived difficulties falling and/or staying asleep. Items are rated on a 5-point rating scale (1=no problem, 5=very much a problem). The summed raw score is converted into a normed T-score (mean=50, SD=10). Higher T-scores reflect more sleep disturbance.

Time frame:
From pre-treatment assessment to post-treatment assessment, up to approximately 10 weeks
Reported as:
Mean · t-score
Change From Baseline Psychosocial Function (Sleep), as Measured by the PROMIS Sleep Disturbance
t-scoreCognitive Rehabilitation + Occupational Therapy (Telerehabilitation)
Change From Baseline Psychosocial Function (Sleep), as Measured by the PROMIS Sleep Disturbance-2.58 ± 11.98
Statistical analysis
  • Cognitive Rehabilitation + Occupational Therapy (Telerehabilitation) · t-test, 2 sided · p = .361 · Mean difference (final values): -2.6 · 95% CI -8.4 to 3.2

Adverse events

Collected over From enrollment until post-treatment assessment at the end of the study (approximately 10 weeks).. Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Cognitive Rehabilitation + Occupational Therapy (Telerehabilitation)0/20 (0%)0/20 (0%)6/20 (30%)
Most frequent other events
Most frequent other events
EventCognitive Rehabilitation + Occupational Therapy (Telerehabilitation)
Elbow painMusculoskeletal and connective tissue disorders2/20
LacerationInjury, poisoning and procedural complications1/20
Dental procedureSurgical and medical procedures1/20
DizzinessGeneral disorders1/20
BruiseInjury, poisoning and procedural complications1/20

Baseline characteristics

Age, Continuous
Age, Continuous(years)Cognitive Rehabilitation + Occupational Therapy (Telerehabilitation)
Mean57.6 ± 12
Sex: Female, Male
Sex: Female, Male(Participants)Cognitive Rehabilitation + Occupational Therapy (Telerehabilitation)
Female10
Male10
Race (NIH/OMB)
Race (NIH/OMB)(Participants)Cognitive Rehabilitation + Occupational Therapy (Telerehabilitation)
American Indian or Alaska Native0
Asian0
Native Hawaiian or Other Pacific Islander1
Black or African American5
White13
More than one race0
Unknown or Not Reported1
Ethnicity (NIH/OMB)
Ethnicity (NIH/OMB)(Participants)Cognitive Rehabilitation + Occupational Therapy (Telerehabilitation)
Hispanic or Latino1
Not Hispanic or Latino19
Unknown or Not Reported0
Montreal Cognitive Assessment (MoCA)
Montreal Cognitive Assessment (MoCA)(score on scale)Cognitive Rehabilitation + Occupational Therapy (Telerehabilitation)
Mean23.7 ± 3.7
Patient Specific Functional Scale (PSFS)
Patient Specific Functional Scale (PSFS)(score on scale)Cognitive Rehabilitation + Occupational Therapy (Telerehabilitation)
Mean2.2 ± 1.6
Patient Health Questionnaire (PHQ-9)
Patient Health Questionnaire (PHQ-9)(score on scale)Cognitive Rehabilitation + Occupational Therapy (Telerehabilitation)
Mean5.4 ± 4.9
NeuroQoL-Cognitive Function
NeuroQoL-Cognitive Function(t-score)Cognitive Rehabilitation + Occupational Therapy (Telerehabilitation)
Mean46.6 ± 11.0

4 further baseline measures are reported on the registry.

08

Study locations

1 site
  • Medical University of South Carolina
    Charleston, South Carolina 29425, United States
09

References and documents

Study documents

  • Protocol and statistical analysis plan · Oct 7, 2024
  • Informed consent form · Oct 8, 2024

Documents are hosted by the registry — open the source record to download them.

Individual participant data

Plan to share: Yes — De-identified data will be shared in the NIH-funded Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) Data and Specimen Hub (DASH).

10

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jun 3, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT06555302
Lead sponsor
Medical University of South Carolina
Collaborators
National Institute of General Medical Sciences (NIGMS)
Responsible party
Stephanie Aghamoosa (Assistant Professor-Faculty, Medical University of South Carolina) — Principal investigator
First posted
Aug 15, 2024
Start date
Aug 20, 2024
Primary completion
Apr 9, 2025
Completion
Apr 9, 2025
Results posted
May 14, 2026
Last update
Jun 3, 2026

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in May 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion